Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich plasma plus tranexamic acid vs tranexamic acid for macular amyloidosis
IRCT20220808055641N4Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Macular Amyloidosis comparing Tranexamic acid alone with Tranexamic acid plus platelet-rich plasma (2 arms). Started Feb 2024; status: completed.
02
Drugs
tranexamic acidplatelet-rich plasma
03
Conditions
Macular Amyloidosis
Beyond the preview
Go deeper on IRCT20220808055641N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220808055641N4.